Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

被引：194
|
作者：
Winter, Jordan M. [1 ]
Yeo, Charles J. [1 ]
Brody, Jonathan R. [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2013年 / 107卷 / 01期
关键词：
pancreatic cancer; pancreatic ductal adenocarcinoma; biomarkers; predictive markers; prognostic markers; SERUM CA-19-9 LEVELS; GENE-EXPRESSION; ADJUVANT CHEMOTHERAPY; PHOSPHOGLYCERATE KINASE-1; DUCTAL ADENOCARCINOMA; CA19-9; LEVELS; SURVIVAL; GEMCITABINE; RECURRENCE; IDENTIFICATION;
D O I：
10.1002/jso.23192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Serum CA 19-9 is the only FDA approved biomarker recommended for use in the routine management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies related to pancreatic cancer appear in the literature, highlighting the need to discover and develop improved tests. Diagnostic biomarkers have implications for early detection of PDA, prognostic markers predict patient survival and recurrence patterns, and predictive markers can help personalize treatment regimens. J. Surg. Oncol. 2013;107:1522. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码：15 / 22
页数：8
相关论文
共 50 条
  • [1] Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
    Giannis, Dimitrios
    Moris, Dimitrios
    Barbas, Andrew S.
    CANCERS, 2021, 13 (05) : 1 - 17
  • [2] The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
    Maloney, Sarah
    Clarke, Stephen J.
    Sahni, Sumit
    Hudson, Amanda
    Colvin, Emily
    Mittal, Anubhav
    Samra, Jaswinder
    Pavlakis, Nick
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13437 - 13450
  • [3] Biomarkers in Pancreatic Cancer Diagnostic, Prognostic, and Predictive
    Fong, Zhi Ven
    Winter, Jordan M.
    CANCER JOURNAL, 2012, 18 (06) : 530 - 538
  • [4] Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
    Khomiak, Andrii
    Brunner, Marius
    Kordes, Maximilian
    Lindblad, Stina
    Miksch, Rainer Christoph
    Ohlund, Daniel
    Regel, Ivonne
    CANCERS, 2020, 12 (11) : 1 - 20
  • [5] The prognostic and predictive value of serum CA19.9 in pancreatic cancer
    Humphris, J. L.
    Chang, D. K.
    Johns, A. L.
    Scarlett, C. J.
    Pajic, M.
    Jones, M. D.
    Colvin, E. K.
    Nagrial, A.
    Chin, V. T.
    Chantrill, L. A.
    Samra, J. S.
    Gill, A. J.
    Kench, J. G.
    Merrett, N. D.
    Das, A.
    Musgrove, E. A.
    Sutherland, R. L.
    Biankin, A. V.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1713 - 1722
  • [6] The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
    Sarah Maloney
    Stephen J. Clarke
    Sumit Sahni
    Amanda Hudson
    Emily Colvin
    Anubhav Mittal
    Jaswinder Samra
    Nick Pavlakis
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13437 - 13450
  • [7] Potential diagnostic, prognostic, and predictive biomarkers of gastric cancer
    Mohammed, Ousman
    Gizaw, Solomon Tebeje
    Degef, Maria
    HEALTH SCIENCE REPORTS, 2024, 7 (07)
  • [8] microRNA based prognostic biomarkers in pancreatic Cancer
    Guo, Shixiang
    Fesler, Andrew
    Wang, Huaizhi
    Ju, Jingfang
    BIOMARKER RESEARCH, 2018, 6
  • [9] Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
    Gablo, Natalia A.
    Prochazka, Vladimir
    Kala, Zdenek
    Slaby, Ondrej
    Kiss, Igor
    CURRENT GENOMICS, 2019, 20 (08) : 569 - 580
  • [10] Progress on diagnostic and prognostic markers of pancreatic cancer
    Yang, Hong
    LI, Wan
    Ren, Liwen
    Yang, Yihu
    Zhang, Yizhi
    Ge, Binbin
    LI, Sha
    Zheng, Xiangjin
    Liu, Jinyi
    Zhang, Sen
    DU, Guanhua
    Tang, Bo
    Wang, Hongquan
    Wang, Jinhua
    ONCOLOGY RESEARCH, 2023, 31 (02) : 83 - 99
12345